Published in Clin Sci (Lond) on September 01, 1985
Current devices of respiratory physiotherapy. Hippokratia (2008) 0.82
Effect of external high-frequency oscillation on severe cardiogenic pulmonary edema. J Anesth (1997) 0.78
Two-, six-, and 12-minute walking tests in respiratory disease. Br Med J (Clin Res Ed) (1982) 7.77
Oxygen relieves breathlessness in "pink puffers". Lancet (1981) 3.64
Pulmonary fibrosis associated with hypersensitivity to gold salts. Br Med J (1976) 2.91
Progressive airway obliteration in adults and its association with rheumatoid disease. Q J Med (1977) 2.83
The natural history of lung cancer: a review based on rates of tumour growth. Br J Dis Chest (1979) 2.76
Drug treatment of breathlessness: contrasting effects of diazepam and promethazine in pink puffers. Br Med J (Clin Res Ed) (1981) 2.74
Cystic fibrosis in the mouse by targeted insertional mutagenesis. Nature (1992) 2.66
Prognostic significance of laboratory parameters measured at diagnosis in small cell carcinoma of the lung. Cancer Res (1985) 2.62
Long-term prospective evaluation of offspring of diabetic mothers. Diabetes (1991) 2.53
Theophylline prescribing, serum concentrations, and toxicity. Lancet (1983) 2.40
Radiotherapy in small cell cancer of the lung treated with combination chemotherapy: a controlled trial. Br Med J (Clin Res Ed) (1984) 2.19
Inhaled corticosteroids: benefits and risks. Thorax (1992) 2.17
Protocols for in vivo measurement of the ion transport defects in cystic fibrosis nasal epithelium. Eur Respir J (1994) 2.07
Effects of dihydrocodeine, alcohol, and caffeine on breathlessness and exercise tolerance in patients with chronic obstructive lung disease and normal blood gases. N Engl J Med (1981) 1.94
An MTP inhibitor that normalizes atherogenic lipoprotein levels in WHHL rabbits. Science (1998) 1.93
A comparison of educational interventions. Multimedia textbook, standard lecture, and printed textbook. Arch Pediatr Adolesc Med (1995) 1.88
Amphotericin B lipid complex therapy of experimental fungal infections in mice. Antimicrob Agents Chemother (1991) 1.88
Duration of chemotherapy in small cell lung cancer: a Cancer Research Campaign trial. Br J Cancer (1989) 1.81
Medium term treatment of stable stage cystic fibrosis with recombinant human DNase I. Thorax (1995) 1.72
Efficient gene transfer to airway epithelium using recombinant Sendai virus. Nat Biotechnol (2000) 1.71
alpha 1-antitrypsin phenotypes in fibrosing alveolitis and rheumatoid arthritis. Lancet (1977) 1.70
Absorption of glycine and glycine peptides from the small intestine of the rat. Clin Sci (1968) 1.69
Cationic lipid-mediated CFTR gene transfer to the lungs and nose of patients with cystic fibrosis: a double-blind placebo-controlled trial. Lancet (1999) 1.69
Pseudo-steroid resistant asthma. Thorax (1999) 1.67
Atelectasis and survival after bronchoscopic lung volume reduction for COPD. Eur Respir J (2010) 1.65
Islet-cell-surface antibodies in juvenile diabetes mellitus. N Engl J Med (1978) 1.59
BOOP and COP. Thorax (1991) 1.57
Effect of inhaled furosemide on metabisulfite- and methacholine-induced bronchoconstriction and nasal potential difference in asthmatic subjects. Am Rev Respir Dis (1990) 1.57
Non-invasive liposome-mediated gene delivery can correct the ion transport defect in cystic fibrosis mutant mice. Nat Genet (1993) 1.55
Inflammation in cystic fibrosis airways: relationship to increased bacterial adherence. Eur Respir J (2001) 1.55
Mannose-binding lectin is present in the infected airway: a possible pulmonary defence mechanism. Thorax (2008) 1.54
High-risk obstetric patients. Maternal morbidity after cesareans. J Reprod Med (1997) 1.43
Collateral ventilation. Thorax (2006) 1.42
Incidence of gram-negative bacteraemia in sepsis syndrome. Implications for immunotherapy. Anaesthesia (1994) 1.41
Inhaled corticosteroids: benefits and risks. J Asthma (1996) 1.39
Nedocromil sodium workshop. Respir Med (1989) 1.38
Wegener's granuloma. A series of 265 British cases seen between 1975 and 1985. A report by a sub-committee of the British Thoracic Society Research Committee. Q J Med (1992) 1.37
Treating patients with asthma who are dependent on systemic steroids. BMJ (1989) 1.37
Pseudoexfoliation in South India. Br J Ophthalmol (2003) 1.37
Bronchoscopic and percutaneous aspiration biopsy in the diagnosis of bronchial carcinoma cell type. Thorax (1982) 1.36
Delivering CPAP with a siemens Servo 900B ventilator. Intensive Care Med (1990) 1.36
Patients at risk of chemotherapy-associated toxicity in small cell lung cancer. Br J Cancer (1989) 1.32
Nasal potential difference: a clinical diagnostic test for cystic fibrosis. Eur Respir J (1990) 1.32
Dihydrocodeine for breathlessness in "pink puffers". Br Med J (Clin Res Ed) (1983) 1.32
Airways obstruction in rheumatoid arthritis. Ann Rheum Dis (1979) 1.31
FGF-2 enhances intestinal stem cell survival and its expression is induced after radiation injury. Am J Physiol (1999) 1.30
Newly diagnosed cystic fibrosis in middle and later life. Thorax (1985) 1.30
Fibreoptic bronchoscopy: effect of multiple bronchial biopsies on diagnostic yield in bronchial carcinoma. Thorax (1982) 1.27
Upper respiratory tract viral infection and mucociliary clearance. Eur J Respir Dis (1987) 1.23
Plasma levels, half-life values, and correlation with physiologic assays for growth and immunity. J Pediatr (1978) 1.21
Spinal cord compression in small cell lung cancer: a retrospective study of 610 patients. Br J Cancer (1989) 1.20
Virilizing adrenocortical tumors in childhood: eight cases and a review of the literature. Pediatrics (1985) 1.20
A randomised trial of planned versus as required chemotherapy in small cell lung cancer: a Cancer Research Campaign trial. Br J Cancer (1991) 1.19
Supplemental oxygen and exercise ability in chronic obstructive airways disease. Thorax (1988) 1.19
Keratinocyte growth factor therapy in murine oleic acid-induced acute lung injury. Am J Physiol Lung Cell Mol Physiol (2005) 1.18
No added benefit from nebulized amiloride in patients with cystic fibrosis. Eur Respir J (1993) 1.18
Longitudinal follow-up comparison of educational interventions: multimedia textbook, traditional lecture, and printed textbook. Acad Radiol (1997) 1.16
Diabetic ketoacidosis. Induction of hypocalcemia and hypomagnesemia by phosphate therapy. Am J Med (1979) 1.15
Airway surface pH in subjects with cystic fibrosis. Eur Respir J (2003) 1.15
Randomised, double-blind, placebo-controlled trial of methotrexate in steroid-dependent asthma. Lancet (1990) 1.14
Nasal epithelial ion transport and genetic analysis of infertile men with congenital bilateral absence of the vas deferens. Hum Mol Genet (1993) 1.14
Sendai virus-mediated CFTR gene transfer to the airway epithelium. Gene Ther (2007) 1.13
Two years experience with recombinant human DNase I in the treatment of pulmonary disease in cystic fibrosis. Respir Med (1995) 1.13
Asbestosis: assessment by bronchoalveolar lavage and measurement of pulmonary epithelial permeability. Thorax (1985) 1.12
Recurrence of recipient Langerhans' cell histiocytosis following bilateral lung transplantation. Thorax (1998) 1.11
Neonatology and residency training: enough is enough. Am J Dis Child (1990) 1.08
High frequency oscillations improve nasal mucociliary transport. Lancet (1984) 1.08
Exhaled 8-isoprostane as a new non-invasive biomarker of oxidative stress in cystic fibrosis. Thorax (2000) 1.08
Social consequences of brain or liver relapse in small cell carcinoma of the bronchus. Radiother Oncol (1985) 1.06
Idiopathic hypothalamic dysfunction and impaired control of breathing. Pediatrics (1985) 1.06
Pulmonary disease severity in men with deltaF508 cystic fibrosis and residual chloride secretion. Lancet (1999) 1.05
Effect of nitrazepam and flurazepam on the ventilatory response to carbon dioxide. Thorax (1976) 1.04
A randomized controlled evaluation of specialist nurse education following accident and emergency department attendance for acute asthma. Respir Med (2000) 1.04
Reproducibility of dynamically represented acoustic lung images from healthy individuals. Thorax (2007) 1.03
Depression of central respiratory drive by nitrazepam. Thorax (1978) 1.03
Erythromycin and diffuse panbronchiolitis. Thorax (1997) 1.03
Chronic hypoxia impairs soluble guanylyl cyclase-mediated pulmonary arterial relaxation in the rat. Am J Physiol (1992) 1.02
Dornase alfa for cystic fibrosis. Patients should not be denied a safe, effective treatment. BMJ (1995) 1.02
The effect of isoprenaline on plasma renin activity in man: a dose-response curve. Clin Endocrinol (Oxf) (1977) 1.01
The extra- and intracellular barriers to lipid and adenovirus-mediated pulmonary gene transfer in native sheep airway epithelium. Gene Ther (1999) 1.01
Profiles of metabolic control in diabetic children-frequency of asymptomatic nocturnal hypoglycemia. Metabolism (1981) 1.01
Tumor size, response rate, and prognosis in small cell carcinoma of the bronchus treated by combination chemotherapy. Cancer Treat Rep (1982) 1.01
Self-administered home intravenous antibiotic therapy in bronchiectasis and adult cystic fibrosis. Lancet (1984) 1.01
Inhibition of exercise-induced asthma by an orally absorbed mast cell stabilizer (M & B 22,948). Br J Dis Chest (1983) 1.01
Absence of the plasma growth hormone-binding protein in Laron-type dwarfism. J Clin Endocrinol Metab (1987) 1.00
Pulmonary deposition of nebulised amiloride in cystic fibrosis: comparison of two nebulisers. Thorax (1991) 0.99
Absence of electrochemical defect of cystic fibrosis in transplanted lung. Lancet (1987) 0.98
Mucus altering agents as adjuncts for nonviral gene transfer to airway epithelium. Gene Ther (2001) 0.98
Bronchoalveolar lavage in the diagnosis of diffuse pulmonary shadowing. Br J Dis Chest (1984) 0.98
Multiple site phosphorylation of tyrosine hydroxylase. Differential regulation in situ by a 8-bromo-cAMP and acetylcholine. J Biol Chem (1982) 0.98
Poly (D, L-lactide-co-glycolide)/DNA microspheres to facilitate prolonged transgene expression in airway epithelium in vitro, ex vivo and in vivo. Gene Ther (2003) 0.97
Cyclosporin as an oral corticosteroid sparing agent in stable asthma. Cochrane Database Syst Rev (2001) 0.96
Sarcoidosis in two patients with cystic fibrosis: a fortuitous association? Thorax (1987) 0.96
Measurement of nasal potential difference in adult cystic fibrosis, Young's syndrome, and bronchiectasis. Thorax (1987) 0.96
Morphological and secretory properties of bronchoalveolar lavage mast cells in respiratory diseases. Clin Allergy (1986) 0.96
Allergic bronchopulmonary aspergillosis: a review. J R Soc Med (1992) 0.95